Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

被引：58

作者：

Fendler, Annika ^{[1
]}

Shepherd, Scott T. C. ^{[1
,14
,15
]}

Au, Lewis ^{[1
,14
,15
]}

Wu, Mary ^{[2
]}

Harvey, Ruth ^{[3
]}

Schmitt, Andreas M. ^{[14
,15
]}

Tippu, Zayd ^{[1
,14
,15
]}

Shum, Benjamin ^{[1
,14
,15
]}

Farag, Sheima ^{[14
,15
]}

Rogiers, Aljosja ^{[14
,15
]}

Carlyle, Eleanor ^{[14
,15
]}

Edmonds, Kim ^{[14
,15
]}

Del Rosario, Lyra ^{[14
,15
]}

Lingard, Karla ^{[14
,15
]}

Mangwende, Mary ^{[14
,15
]}

Holt, Lucy ^{[14
,15
]}

Ahmod, Hamid ^{[14
,15
]}

Korteweg, Justine ^{[14
,15
]}

Foley, Tara ^{[14
,15
]}

Barber, Taja ^{[1
]}

Emslie-Henry, Andrea ^{[1
]}

Caulfield-Lynch, Niamh ^{[1
]}

Byrne, Fiona ^{[1
]}

Deng, Daqi ^{[1
]}

Kjaer, Svend ^{[4
]}

Song, Ok-Ryul ^{[2
]}

Queval, Christophe ^{[2
]}

Kavanagh, Caitlin ^{[2
]}

Wall, Emma C. ^{[2
,23
]}

Carr, Edward J. ^{[5
]}

Caidan, Simon ^{[6
]}

Gavrielides, Mike ^{[7
]}

MacRae, James I. ^{[8
]}

Kelly, Gavin ^{[9
]}

Peat, Kema ^{[14
,15
]}

Kelly, Denise ^{[14
,15
]}

Murra, Aida ^{[14
,15
]}

Kelly, Kayleigh ^{[14
,15
]}

O'Flaherty, Molly ^{[14
,15
]}

Shea, Robyn L. ^{[16
,24
]}

Gardner, Gail ^{[16
]}

Murray, Darren ^{[16
]}

Yousaf, Nadia ^{[17
,18
]}

Jhanji, Shaman ^{[19
]}

Tatham, Kate ^{[19
]}

Cunningham, David ^{[20
]}

Van As, Nicholas ^{[21
]}

Young, Kate ^{[14
,15
]}

Furness, Andrew J. S. ^{[14
,15
]}

Pickering, Lisa ^{[14
,15
]}

机构：

[1] Francis Crick Inst, Canc Dynam Lab, London NW1 1AT, England

[2] Francis Crick Inst, High Throughput Screening Lab, London NW1 1AT, England

[3] Francis Crick Inst, Worldwide Influenza Ctr, London NW1 1AT, England

[4] Francis Crick Inst, Struct Biol Sci Technol Platform, London NW1 1AT, England

[5] Francis Crick Inst, Cell Biol Infect Lab, London NW1 1AT, England

[6] Francis Crick Inst, Safety Hlth & Sustainabil, London NW1 1AT, England

[7] Francis Crick Inst, Sci Comp Sci Technol Platform, London NW1 1AT, England

[8] Francis Crick Inst, Metabol Sci Technol Platform, London NW1 1AT, England

[9] Francis Crick Inst, Dept Bioinformat & Biostat, London NW1 1AT, England

[10] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London NW1 1AT, England

[11] Francis Crick Inst, Neurodegenerat Biol Lab, London NW1 1AT, England

[12] Francis Crick Inst, Struct Biol Dis Processes Lab, London NW1 1AT, England

[13] Francis Crick Inst, RNA Virus Replicat Lab, London NW1 1AT, England

[14] Royal Marsden NHS Fdn Trust, Skin Unit, London, England

[15] Royal Marsden NHS Fdn Trust, Renal Unit, London, England

[16] Royal Marsden NHS Fdn Trust, Dept Pathol, London, England

[17] Royal Marsden NHS Fdn Trust, Lung Unit, London, England

[18] Royal Marsden NHS Fdn Trust, Acute Oncol Serv, London, England

[19] Royal Marsden NHS Fdn Trust, Anaesthet Perioperat Med & Pain Dept, London, England

[20] Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, London, England

[21] Royal Marsden NHS Fdn Trust, Clincal Oncol Unit, London, England

[22] Royal Marsden NHS Fdn Trust, Haematooncol Unit, London, England

[23] Univ Coll London Hosp NHS Fdn Trust, Biomed Res Ctr, London, England

[24] Inst Canc Res, Translat Canc Biochem Lab, London, England

[25] Inst Canc Res, Melanoma & Kidney Canc Team, London, England

[26] UCL, Div Med, London, England

[27] UCL, Inst Canc, London, England

[28] UCL Queen Sq Inst Neurol, London, England

来源：

LANCET | 2022年 / 399卷 / 10328期

关键词：

D O I：

10.1016/S0140-6736(22)00147-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：905 / 907

页数：3

共 50 条

[1] Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients
Carr, Edward J.
Wu, Mary
Harvey, Ruth
Billany, Roseanne E.
Wall, Emma C.
Kelly, Gavin
Howell, Michael
Kassiotis, George
Swanton, Charles
Gandhi, Sonia
Bauer, David L. V.
Graham-Brown, Matthew P. M.
Jones, Rachel B.
Smith, Rona M.
McAdoo, Stephen
Willicombe, Michelle
Beale, Rupert
LANCET, 2022, 399 (10327): : 800 - 802
[2] Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients
Carr, Edward J.
Wu, Mary
Harvey, Ruth
Wall, Emma C.
Kelly, Gavin
Hussain, Saira
Howell, Michael
Kassiotis, George
Swanton, Charles
Gandhi, Sonia
Bauer, David L. V.
Billany, Roseanne E.
Graham-Brown, Matthew P. M.
Beckett, Joseph
Bull, Katherine
Shankar, Sushma
Henderson, Scott
Motallebzadeh, Reza
Salama, Alan D.
Harper, Lorraine
Mark, Patrick B.
McAdoo, Stephen
Willicombe, Michelle
Beale, Rupert
LANCET, 2021, 398 (10305): : 1038 - 1041
[3] Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
Douglas F. Lake
Alexa J. Roeder
Maria J. Gonzalez-Moa
Megan Koehler
Erin Kaleta
Paniz Jasbi
John Vanderhoof
Davis McKechnie
Jack Forman
Baylee A. Edwards
Alim Seit-Nebi
Sergei Svarovsky
Communications Medicine, 2
[4] Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
Lake, Douglas. F.
Roeder, Alexa. J.
Gonzalez-Moa, Maria. J.
Koehler, Megan
Kaleta, Erin
Jasbi, Paniz
Vanderhoof, John
McKechnie, Davis
Forman, Jack
Edwards, Baylee. A.
Seit-Nebi, Alim
Svarovsky, Sergei
COMMUNICATIONS MEDICINE, 2022, 2 (01):
[5] Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
Milja Belik
Pinja Jalkanen
Rickard Lundberg
Arttu Reinholm
Larissa Laine
Elina Väisänen
Marika Skön
Paula A. Tähtinen
Lauri Ivaska
Sari H. Pakkanen
Hanni K. Häkkinen
Eeva Ortamo
Arja Pasternack
Mikael A. Ritvos
Rauno A. Naves
Simo Miettinen
Tarja Sironen
Olli Vapalahti
Olli Ritvos
Pamela Österlund
Anu Kantele
Johanna Lempainen
Laura Kakkola
Pekka Kolehmainen
Ilkka Julkunen
Nature Communications, 13
[6] Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
Belik, Milja
Jalkanen, Pinja
Lundberg, Rickard
Reinholm, Arttu
Laine, Larissa
Vaisanen, Elina
Skon, Marika
Tahtinen, Paula A.
Ivaska, Lauri
Pakkanen, Sari H.
Hakkinen, Hanni K.
Ortamo, Eeva
Pasternack, Arja
Ritvos, Mikael A.
Naves, Rauno A.
Miettinen, Simo
Sironen, Tarja
Vapalahti, Olli
Ritvos, Olli
Osterlund, Pamela
Kantele, Anu
Lempainen, Johanna
Kakkola, Laura
Kolehmainen, Pekka
Julkunen, Ilkka
NATURE COMMUNICATIONS, 2022, 13 (01)
[7] Lymphadenopathy after the third Covid-19 vaccine
Ozutemiz, Can
Potter, David A.
Ozutemiz, Ayca Ozbek
Steinberger, Daniel
CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 4
[8] Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
Reactions Weekly, 2022, 1900 (1) : 10 - 10
[9] HETEROLOGOUS THIRD AND FOURTH DOSE VACCINE TO REDUCE SEVERITY AND MORTALITY IN COVID-19 PATIENTS DURING DELTA AND OMICRON PREDOMINANT IN THAILAND
Chariyalertsak, S.
Intawong, K.
Chalom, K.
Wonghirundecha, T.
Kowatcharakul, W.
Ayood, P.
Thongprachum, A.
Chotirosniramit, N.
Noppakun, K.
Teacharak, W.
Khammawan, P.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S135 - S135
[10] Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
Regev-Yochay, Gili
Gonen, Tal
Gilboa, Mayan
Mandelboim, Michal
Indenbaum, Victoria
Amit, Sharon
Meltzer, Lilac
Asraf, Keren
Cohen, Carmit
Fluss, Ronen
Biber, Asaf
Nemet, Ital
Kliker, Limor
Joseph, Gili
Doolman, Ram
Mendelson, Ella
Freedman, Laurence S.
Harats, Dror
Kreiss, Yitshak
Lustig, Yaniv
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (14): : 1377 - 1380

← 1 2 3 4 5 →